首页> 外文期刊>International journal of biological sciences >Garlic oil attenuated nitrosodiethylamine-induced hepatocarcinogenesis by modulating the metabolic activation and detoxification enzymes
【24h】

Garlic oil attenuated nitrosodiethylamine-induced hepatocarcinogenesis by modulating the metabolic activation and detoxification enzymes

机译:通过调节代谢活化和排毒酶,大蒜油衰减亚硝基二乙胺诱导的肝癌发生器

获取原文
获取原文并翻译 | 示例
           

摘要

Nitrosodiethylamine (NDEA) is a potent carcinogen widely existing in the environment. Our previous study has demonstrated that garlic oil (GO) could prevent NDEA-induced hepatocarcinogenesis in rats, but the underlying mechanisms are not fully understood. It has been well documented that the metabolic activation may play important roles in NDEA-induced hepatocarcinogenesis. Therefore, we designed the current study to explore the potential mechanisms by investigating the changes of hepatic phase I enzymes (including cytochrome P450 enzyme (CYP) 2E1, CYP1A2 and CYP1A1) and phase II enzymes (including glutathione S transferases (GSTs) and UDP-Glucuronosyltransferases (UGTs)) by using enzymatic methods, real-time PCR, and western blotting analysis. We found that NDEA treatment resulted in significant decreases of the activities of CYP2E1, CYP1A2, GST alpha, GST mu, UGTs and increases of the activities of CYP1A1 and GST pi. Furthermore, the mRNA and protein levels of CYP2E1, CYP1A2, GST alpha, GST mu and UGT1A6 in the liver of NDEA-treated rats were significantly decreased compared with those of the control group rats, while the mRNA and protein levels of CYP1A1 and GST pi were dramatically increased. Interestingly, all these adverse effects induced by NDEA were simultaneously and significantly suppressed by GO co-treatment. These data suggest that the protective effects of GO against NDEA-induced hepatocarcinogenesis might be, at least partially, attributed to the modulation of phase I and phase II enzymes.
机译:亚硝基二乙胺(NDEA)是环境中广泛存在的有效的致癌物质。我们以前的研究表明,大蒜油(GO)可以预防大鼠的NDEA诱导的肝癌,但潜在机制尚未完全理解。它已经详细记录了代谢激活可能在NDEA诱导的肝癌发生中起重要作用。因此,我们设计了目前的研究,通过研究肝相I酶的变化(包括细胞色素P450酶(CYP)2E1,CYP1A2和CYP1A1)和II酶(包括谷胱甘肽S转移酶(GSTS)和UDP - )来探索潜在机制葡萄糖醛糖基转移酶(UGTS))通过使用酶法,实时PCR和Western印迹分析。我们发现NDEA治疗导致CYP2E1,CYP1A2,GSTα,GST亩,UGTS和CYP1A1和GST PI的活性的显着降低。此外,与对照组大鼠的肝脏的肝脏中CYP2E1,CYP1A2,GSTα,GST mu和Ugt1a6的MRNA和蛋白水平显着降低,而CYP1A1和GST PI的mRNA和蛋白质水平显着降低急剧增加。有趣的是,NDEA诱导的所有这些不良反应同时抑制了同期抑制。这些数据表明,逆对抗NDEA诱导的肝癌发生的保护作用至少部分地归因于调节I I和II酶的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号